BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
340.38
-9.62 (-2.75%)
Jan 30, 2026, 4:00 PM EST - Market closed
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of $37.67 billion as of February 2, 2026. Its market cap has increased by 75.19% in one year.
Market Cap
37.67B
Enterprise Value
34.65B
1-Year Change
75.19%
Ranking
Category
Stock Price
$340.38
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from $861.90M to $37.67B, an increase of 4,270.08%. That is a compound annual growth rate of 45.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 37.65B | 12.04% |
| Dec 31, 2025 | 33.61B | 70.71% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 76.07B |
| argenx SE | 51.17B |
| Alnylam Pharmaceuticals | 44.66B |
| Insmed | 33.46B |
| BioNTech SE | 28.54B |
| Royalty Pharma | 24.06B |
| Genmab | 19.81B |
| Incyte | 19.65B |